Northpond Ventures leads Series E round for 908 Devices
Boston-based 908 Devices, a provider of analytical devices for chemical and biomolecular analysis, has secured $17.5 million in Series E funding. Northpond Ventures led the round. In addition to the funding, Northpond's Sharon Kedar, a co-founder and partner at the firm, will join 908 as a member of the board.
29 April 2019•1 min read
